VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ABT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ABTAbbott Laboratories
$104.48$182.0B
Overview & Tools
OverviewChart Terminal ↗AnalysisVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksABTQuarterly Financials

Abbott Laboratories (ABT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Abbott Laboratories (ABT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ABT Income Statement

Quarterly statement

ABT Income Statement

Abbott Laboratories (ABT) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue13.01B12.59B11.16B11.46B11.37B11.14B10.36B10.97B10.63B10.38B9.96B10.24B10.14B9.98B9.75B10.09B10.41B11.26B11.89B11.47B
Revenue Growth %14.46%13.02%7.78%4.42%6.9%7.37%3.95%7.16%4.85%4%2.23%1.49%-2.56%-11.36%-18.06%-12.01%-4.74%10.11%13.76%7.17%
Cost of Goods Sold5.63B5.29B4.88B4.92B5.03B4.85B4.91B5.38B5.21B5.07B4.94B4.98B5.11B5.03B4.94B5.12B5.2B5.48B5.53B5.26B
COGS % of Revenue43.25%42%43.72%42.95%44.25%43.56%47.44%48.99%48.98%48.88%49.6%48.66%50.37%50.44%50.7%50.74%49.96%48.71%46.46%45.86%
Gross Profit7.38B7.3B6.28B6.54B6.34B6.29B5.44B5.6B5.43B5.3B5.02B5.26B5.03B4.95B4.8B4.97B5.21B5.77B6.37B6.21B
Gross Margin %56.75%58%56.28%57.05%55.75%56.44%52.56%51.01%51.02%51.12%50.4%51.34%49.63%49.56%49.3%49.26%50.04%51.29%53.54%54.14%
Gross Profit Growth %16.52%16.16%15.41%16.77%16.81%18.53%8.4%6.47%7.79%7.28%4.52%5.77%-3.36%-14.36%-24.56%-19.94%-14.04%7.42%14.34%9.18%
Operating Expenses6.03B5.52B4.44B4.29B4.31B4.24B3.76B3.61B3.61B3.62B3.64B3.39B3.36B3.43B3.4B3.53B3.51B3.44B3.48B3.76B
OpEx % of Revenue46.32%43.85%39.78%37.4%37.89%38.02%36.26%32.88%33.93%34.88%36.5%33.14%33.09%34.42%34.93%34.98%33.68%30.57%29.29%32.8%
Selling, General & Admin4.27B3.98B3.26B3.13B3.1B3.09B3.05B2.88B2.9B2.92B2.95B2.7B2.69B2.72B2.75B2.84B2.73B2.76B2.79B3B
SG&A % of Revenue32.78%31.62%29.23%27.31%27.29%27.76%29.47%26.24%27.22%28.16%29.65%26.4%26.57%27.3%28.22%28.13%26.19%24.49%23.43%26.19%
Research & Development920M882M756M735M785M732M703M728M713M697M683M690M661M710M654M691M780M684M697M758M
R&D % of Revenue7.07%7%6.77%6.41%6.9%6.57%6.79%6.63%6.7%6.72%6.85%6.74%6.52%7.12%6.71%6.85%7.49%6.08%5.86%6.61%
Other Operating Expenses1000K1000K1000K1000K1000K1000K00000000000000
Operating Income1.36B1.78B1.84B2.25B2.06B2.05B1.69B1.99B1.82B1.69B1.39B1.86B1.68B1.51B1.4B1.44B1.7B2.33B2.88B2.45B
Operating Margin %10.44%14.15%16.5%19.64%18.09%18.42%16.3%18.13%17.09%16.25%13.9%18.2%16.54%15.14%14.36%14.28%16.36%20.72%24.25%21.34%
Operating Income Growth %-33.98%-13.16%9.12%13.12%13.15%21.71%21.88%6.76%8.34%11.58%-1.07%29.35%-1.47%-35.23%-51.47%-41.11%-35.05%16.77%35.26%1.37%
EBITDA2.61B2.79B2.57B3.04B2.85B2.83B2.44B2.8B2.62B2.49B2.19B2.68B2.5B2.31B2.21B2.25B2.52B3.15B3.71B3.33B
EBITDA Margin %20.09%22.19%23.04%26.56%25.05%25.39%23.6%25.49%24.63%24.01%21.98%26.14%24.67%23.16%22.63%22.28%24.19%28.03%31.17%29.04%
EBITDA Growth %-8.22%-1.2%5.24%8.8%8.74%13.57%11.6%4.48%4.68%7.79%-0.73%19.08%-0.64%-26.75%-40.51%-32.49%-27.41%9.85%20.9%1.52%
D&A (Non-Cash Add-back)1.26B1.01B730M792M791M777M756M807M801M805M805M813M824M800M806M807M815M822M823M883M
EBIT1.58B1.78B1.52B2.4B2.3B2.27B1.91B2.18B2.11B1.77B1.55B2.03B1.82B1.79B1.72B1.48B1.81B2.44B2.89B2.42B
Net Interest Income-297M-299M-68M-42M33M-50M-52M-61M-75M-86M-37M-146M-51M-55M-61M-76M-1M-59M4M-78M
Interest Income53M0106M78M77M71M82M91M91M82M80M89M97M98M101M88M55M26M14M11M
Interest Expense350M299M174M120M44M121M134M152M166M168M117M235M148M153M162M164M56M85M10M89M
Other Income/Expense-127M-258M-393M107M123M98M90M40M122M-79M51M-69M-7M125M162M-121M55M19M-9M-120M
Pretax Income1.23B1.52B1.45B2.36B2.18B2.15B1.78B2.03B1.94B1.61B1.44B1.79B1.67B1.64B1.56B1.32B1.76B2.35B2.88B2.33B
Pretax Margin %9.46%12.1%12.98%20.58%19.17%19.3%17.17%18.5%18.24%15.49%14.41%17.53%16.47%16.4%16.03%13.08%16.89%20.89%24.18%20.29%
Income Tax311M596M372M582M536M371M453M-7.2B294M305M211M201M235M261M244M287M323M334M429M338M
Effective Tax Rate %25.26%39.11%25.67%24.68%24.59%17.26%25.48%-354.63%15.15%18.98%14.69%11.2%14.06%15.95%15.62%21.74%18.37%14.2%14.92%14.53%
Net Income920M928M1.08B1.78B1.64B1.78B1.32B9.23B1.65B1.3B1.23B1.59B1.44B1.38B1.32B1.03B1.44B2.02B2.45B1.99B
Net Margin %7.07%7.37%9.65%15.5%14.46%15.97%12.79%84.1%15.48%12.55%12.29%15.56%14.16%13.78%13.52%10.24%13.78%17.93%20.57%17.34%
Net Income Growth %-44.04%-47.84%-18.72%-80.76%-0.12%36.64%8.16%478.98%14.62%-5.31%-7.06%54.31%0.07%-31.86%-46.14%-48.06%-31.67%69.72%36.48%-8%
Net Income (Continuing)920M928M1.08B1.78B1.64B1.78B1.32B9.23B1.65B1.3B1.23B1.59B1.44B1.38B1.32B1.03B1.44B2.02B2.45B1.99B
Discontinued Operations00000000000000000000
Minority Interest596M652M640M641M310M264M253M237M232M242M233M224M213M230M222M219M209M226M230M222M
EPS (Diluted)0.530.530.621.020.941.010.765.270.940.740.700.910.820.780.750.590.811.141.381.12
EPS Growth %-43.62%-47.52%-18.24%-80.65%0%36.49%8.34%479.12%14.63%-5.13%-6.67%54.24%1.23%-31.58%-45.65%-47.32%-30.77%72.73%38%-7.44%
EPS (Basic)0.530.530.621.020.941.020.765.330.950.750.710.920.830.790.760.590.821.151.401.13
Diluted Shares Outstanding1.74B1.74B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.75B1.76B1.76B1.77B1.78B
Basic Shares Outstanding1.73B1.74B1.75B1.75B1.75B1.74B1.75B1.73B1.73B1.73B1.73B1.73B1.74B1.74B1.74B1.74B1.74B1.75B1.75B1.76B
Dividend Payout Ratio118.91%118.75%101.95%58%62.71%57.84%77.43%10.38%58.32%73.81%78.12%55.71%61.84%64.73%67.53%79.67%57.56%41.03%34%40.12%